UI 117
Alternative Names: UI-117Latest Information Update: 13 Apr 2026
At a glance
- Originator Korea United Pharm Inc
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Alopecia
Most Recent Events
- 23 Mar 2026 Early research in Alopecia in South Korea (unspecified route) (Korea United Pharm Inc pipeline, March 2026)